tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Alligator Bioscience Secures Funding Through Warrant Exercise

Story Highlights
Alligator Bioscience Secures Funding Through Warrant Exercise

Elevate Your Investing Strategy:

An announcement from Alligator Bioscience AB ( (SE:ATORX) ) is now available.

Alligator Bioscience AB announced the final outcome of its TO 12 warrant exercise, achieving a 71% exercise rate, resulting in the subscription of nearly 14 million new shares. To reach an 85% exercise rate, the company will execute top guarantee commitments, raising approximately SEK 61.5 million, which positions them well for further development and a pivotal Phase 3 trial.

More about Alligator Bioscience AB

Alligator Bioscience AB operates in the biotechnology industry, focusing on developing immunotherapies for cancer treatment. The company is particularly invested in advancing mitazalimab, a potential breakthrough therapy for metastatic pancreatic cancer.

Average Trading Volume: 246,581

Current Market Cap: SEK71M

See more data about ATORX stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1